Zopump D 30mg/20mg Capsule SR is a combination medication containing Domperidone 30mg and Rabeprazole 20mg, formulated as a sustained-release capsule. Domperidone is a peripheral dopamine D2 receptor antagonist that enhances gastrointestinal motility by increasing the movement of the stomach and intestines, thereby facilitating gastric emptying and reducing symptoms of nausea and vomiting. Rabeprazole is a proton pump inhibitor (PPI) that suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, leading to a significant reduction in gastric acidity. This combination is primarily indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, and other acid-related gastrointestinal disorders where delayed gastric emptying contributes to symptomatology. Zopump D is effective in alleviating heartburn, acid regurgitation, and associated dyspeptic symptoms while promoting mucosal healing. The sustained-release formulation ensures prolonged therapeutic effects, improving patient compliance by reducing dosing frequency. It is recommended to be taken orally, preferably before meals. Caution is advised in patients with cardiac arrhythmias or electrolyte imbalances due to the prokinetic effects of Domperidone. Consultation with a healthcare professional is essential before initiating therapy to ensure appropriate use and monitoring.